Search results
Jump to navigation
Jump to search
Page title matches
- ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s which then affect downstream targets (see [http://www.ncbi.nlm.nih.gov/b1 KB (165 words) - 10:54, 9 July 2009
- 183 bytes (23 words) - 02:30, 12 February 2009
- Auto-populated based on [[Special:WhatLinksHere/Protein kinase]]. Needs checking by a human.687 bytes (86 words) - 19:46, 11 January 2010
Page text matches
- Auto-populated based on [[Special:WhatLinksHere/Protein kinase]]. Needs checking by a human.687 bytes (86 words) - 19:46, 11 January 2010
- ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s which then affect downstream targets (see [http://www.ncbi.nlm.nih.gov/b1 KB (165 words) - 10:54, 9 July 2009
- The serine/threonine protein kinase B (PKB) family or Akt is an important downstream signaling component of tyr304 bytes (43 words) - 02:10, 16 May 2009
- {{r|Protein kinase}}641 bytes (79 words) - 16:44, 11 January 2010
- {{r|Protein kinase}}576 bytes (72 words) - 16:44, 11 January 2010
- {{r|Protein kinase inhibitor}}109 bytes (13 words) - 12:24, 31 May 2009
- {{r|Protein kinase||**}}1 KB (156 words) - 08:01, 16 April 2010
- ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s such as [[G-protein-coupled receptor kinase]] which then affect downstre5 KB (679 words) - 09:15, 29 August 2009
- ...pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway."<ref>{{MeSH}} ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s which then affect downstream targets (see [http://www.ncbi.nlm.nih.gov/b2 KB (329 words) - 10:52, 9 July 2009
- ...[[insulin]], and [[oxytocin]] and it has been found to activate specific [[protein kinase]]s."<ref>{{MeSH}}</ref> ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s which then affect downstream targets (see [http://www.ncbi.nlm.nih.gov/b1 KB (203 words) - 10:53, 9 July 2009
- ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s such as [[G-protein-coupled receptor kinase]] which then affect downstre3 KB (338 words) - 13:08, 30 March 2010
- 385 bytes (52 words) - 17:06, 14 May 2010
- {{r|Protein kinase}}1 KB (147 words) - 07:44, 8 January 2010
- ...tion of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase. ([[Medical Subject Headings]])482 bytes (77 words) - 11:57, 2 July 2009
- ===[[Protein kinase]] inhibitors=== {{r|Protein kinase}}4 KB (467 words) - 00:17, 6 February 2009
- ...se-[[cyclic AMP]] primarily and also [[cyclic GMP]] which then activates [[protein kinase]]s.1 KB (147 words) - 06:58, 14 September 2013
- [[Genetic polymorphism]]s of the protein kinase associated with β-2 [[adrenergic receptor]]s may affect the response in [[6 KB (767 words) - 17:34, 10 February 2024
- {{r|Protein kinase}}1 KB (148 words) - 16:21, 11 January 2010
- ...adenyl cyclase-[[cyclic AMP]] and [[cyclic GMP]] which then may activate [[protein kinase]]s which then affect downstream targets (see [http://www.ncbi.nlm.nih.gov/b1 KB (197 words) - 10:52, 9 July 2009
- ...um channels]] in the [[endoplasmic reticulum]] of various cell types and [[protein kinase]] C, respectively.6 KB (929 words) - 15:37, 12 November 2007